Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab

Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab

Davide Allegrini,1 Raffaele Raimondi,2 Giovanni Montesano,3 Alfredo Borgia,2 Tania Sorrentino,2 Panagiotis Tsoutsanis,2 Mario R Romano1,2 1Eye Center, Humanitas, Bergamo, Italy; 2Department of Biomedical Sciences, Humanitas University, Milano, Italy; 3University of London - Optometry and Visual Scie...

Full description

Bibliographic Details
Main Authors: Allegrini D, Raimondi R, Montesano G, Borgia A, Sorrentino T, Tsoutsanis P, Romano MR
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Clinical Ophthalmology
Subjects:
ivt interruption
covid-19
intravitreal injection
bevacizumab
Online Access:https://www.dovepress.com/short-term-outcomes-after-covid-19-related-treatment-interruption-amon-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/short-term-outcomes-after-covid-19-related-treatment-interruption-amon-peer-reviewed-fulltext-article-OPTH

Similar Items